10/11/2013 9:54:05 AM
--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) is a leader in genetic engineering of animals for development of human therapeutic antibodies. The company’s antibody platforms, OmniRat®, OmniMouse® and OmniFlic™ have broad freedom to operate and use technology protected by new patents and patent applications. They are available for licensing worldwide for all targets and indications.
Help employers find you! Check out all the jobs and post your resume.
comments powered by